Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: Nuvalent | Vintage Vibes

Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion

GSK agreed to acquire Nuvalent for $10.6 billion, or $124 per share, a roughly 40% premium, to add two late-stage lung cancer assets and offset an impending patent cliff.

MarketBeat

Nuvalent Stock Hits All-Time High Following GSK's Buyout Offer

Nuvalent shares soar as GSK announces a $10.6 billion buyout deal. But is it too late already to invest in NUVL stock?

Barchart

Why is the US stock market crashing today? S&P 500 erases all gains and wipes out $1.3 trillion in 2 hours as Nasdaq and Dow turn sharply lower - Tech stocks and chip sector collapse

The US stock market crash today caught many investors off guard. Early gains quickly vanished as the S&P 500 erased more than $1.3 trillion in market value within just two hours. What began as a relief rally suddenly turned into a broad sell-off that dragged down the Nasdaq, Nvidia, Apple,…

The Economic Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Nasdaq fall as tech sell off resumes on Wall St

US stocks have closed lower as technology stocks resumed a sell-off after a short-lived bounce and Donald Trump said Iran had shot down a US Apache helicopter.

AAP

US stocks: US market rises as tech shares gain, Middle East tensions ease

Wall Street indexes opened higher on Tuesday, driven by a second consecutive day of gains for chipmakers. Easing Middle East tensions also contributed to positive market sentiment. The Dow Jones Industrial Average, S&P 500, and Nasdaq Composite all saw increases at the opening bell.

The Economic Times

Global Markets: European shares edge higher with banks in the lead; the Middle East in focus

European markets saw a rise on Tuesday. Banking stocks led the gains, with Italian lenders drawing attention. Tech stocks stabilized after recent volatility. GSK shares fell following a deal to acquire Nuvalent. UBS saw an increase on reports of potential capital requirement adjustments. Investors monitored developments in the Middle East…

The Economic Times

GSK makes biggest ever acquisition with $10.6bn for US cancer drug firm

Nuvalent’s late-stage lung cancer treatments zidesamtinib and neladalkib are expected to launch later this year

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

GSK to buy US lung cancer drug specialist Nuvalent for £8bn

The acquisition is thought to be GSK’s biggest deal in more than a decade.

Evening Standard

Nuvalent Reports 31% Response Rate In Patients With Advanced Form Of Lung Cancer

Nuvalent, Inc. (NASDAQ:NUVL) on Monday reported topline results from its ALKOVE-1 Phase 1/2 trial.

Benzinga

$21.8 Million Bet On Nuvalent? 4 Stocks Insiders Are Buying

Although US stocks closed higher on Monday, there were a few notable insider trades.

Benzinga

$7.8 Million Bet On Appian? 4 Stocks Insiders Are Buying

Although US stocks closed lower on Thursday, there were a few notable insider trades.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the European Central Bank

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.